Search Results - "Dillmon, Melissa S"

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline by Dhesy-Thind, Sukhbinder, Fletcher, Glenn G, Blanchette, Phillip S, Clemons, Mark J, Dillmon, Melissa S, Frank, Elizabeth S, Gandhi, Sonal, Gupta, Rasna, Mates, Mihaela, Moy, Beverly, Vandenberg, Ted, Van Poznak, Catherine H

“…Purpose To make recommendations regarding the use of bisphosphonates and other bone-modifying agents as adjuvant therapy for patients with breast cancer…”
Get full text

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update by Van Poznak, Catherine, Somerfield, Mark R, Barlow, William E, Biermann, J Sybil, Bosserman, Linda D, Clemons, Mark J, Dhesy-Thind, Sukhbinder K, Dillmon, Melissa S, Eisen, Andrea, Frank, Elizabeth S, Jagsi, Reshma, Jimenez, Rachel, Theriault, Richard L, Vandenberg, Theodore A, Yee, Gary C, Moy, Beverly

“…Purpose To update, in collaboration with Cancer Care Ontario (CCO), key recommendations of the American Society of Clinical Oncology (ASCO) guideline on the…”
Get full text

Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards by Dillmon, Melissa S, Kennedy, Erin B, Anderson, Mary K, Brodersen, Michael, Cohen, Howard, D Amato, Steven L, Davis, Patty, Doshi, Gury, Genschaw, Stuart, Makhoul, Issam, Ormsby, Wayne, Panikkar, Rajiv, Peng, Eileen, Raez, Luis E, Ronnen, Ellen A, Wimbiscus, Bill, Reff, Michael

“…To provide standards for medically integrated dispensing of oral anticancer drugs and supportive care medications. An Expert Panel was formed, and a systematic…”
Get full text

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update by Eisen, Andrea, Somerfield, Mark R, Accordino, Melissa K, Blanchette, Phillip S, Clemons, Mark J, Dhesy-Thind, Sukhbinder, Dillmon, Melissa S, D'Oronzo, Stella, Fletcher, Glenn G, Frank, Elizabeth S, Hallmeyer, Sigrun, Makhoul, Issam, Moy, Beverly, Thawer, Alia, Wu, Joy Y, Van Poznak, Catherine H

“…To update recommendations of the American Society of Clinical Oncology (ASCO)-Ontario Health (Cancer Care Ontario [CCO]) adjuvant bone-modifying agents in…”
Get full text

Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial by Cobleigh, Melody A, Anderson, Stewart J, Siziopikou, Kalliopi P, Arthur, Douglas W, Rabinovitch, Rachel, Julian, Thomas B, Parda, David S, Seaward, Samantha A, Carter, Dennis L, Lyons, Janice A, Dillmon, Melissa S, Magrinat, Gustav C, Kavadi, Vivek S, Zibelli, Allison M, Tiriveedhi, Lavanya, Hill, Matthew L, Melnik, Marianne K, Beriwal, Sushil, Mamounas, Eleftherios P, Wolmark, Norman

“…Preclinical studies report that trastuzumab (T) can boost radiotherapy (RT) effectiveness. The primary aim of the B-43 trial was to assess the efficacy of RT…”
Get full text

Differential Outcomes in Codon 12/13 and Codon 61 NRAS -Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with NRAS -Mutated Tumors by Cleary, James M, Wang, Victoria, Heist, Rebecca S, Kopetz, E Scott, Mitchell, Edith P, Zwiebel, James A, Kapner, Kevin S, Chen, Helen X, Li, Shuli, Gray, Robert J, McShane, Lisa M, Rubinstein, Larry V, Patton, David R, Meric-Bernstam, Funda, Dillmon, Melissa S, Williams, P Mickey, Hamilton, Stanley R, Conley, Barbara A, Aguirre, Andrew J, O'Dwyer, Peter J, Harris, Lyndsay N, Arteaga, Carlos L, Chen, Alice P, Flaherty, Keith T

“…Preclinical and clinical data suggest that downstream inhibition with an MEK inhibitor, such as binimetinib, might be efficacious for -mutated cancers…”
Get full text

Unusual thromboses associated with protein S deficiency in patients with acquired immunodeficiency syndrome: case reports and review of the literature by Dillmon, Melissa S, Saag, Michael S, Hamza, Sate H, Adler, Brian K, Marques, Marisa B

“…Recent reports indicate that patients infected with HIV are at increased risk for the development of thrombosis. Among other possibilities, an acquired…”
Get more information

Differential Outcomes in Codon 12/13 and Codon 61 NRAS-Mutated Cancers in the Phase 2 NCI-MATCH Trial of Binimetinib in Patients with NRAS-Mutated Tumors by Cleary, James M., Wang, Victoria, Heist, Rebecca S., Kopetz, E. Scott, Mitchell, Edith P., Zwiebel, James A., Kapner, Kevin S., Chen, Helen X., Li, Shuli, Gray, Robert J., McShane, Lisa M., Rubinstein, Larry V., Patton, David R., Meric-Bernstam, Funda, Dillmon, Melissa S., Williams, P. Mickey, Hamilton, Stanley R., Conley, Barbara A., Aguirre, Andrew J., O’Dwyer, Peter J., Harris, Lyndsay N., Arteaga, Carlos L., Chen, Alice P., Flaherty, Keith T.

Get full text

Primary results of NRG Oncology / NSABP B-43: Phase III trial comparing concurrent trastuzumab (T) and radiation therapy (RT) with RT alone for women with HER2-positive ductal carcinoma in situ (DCIS) after lumpectomy by Cobleigh, Melody A., Anderson, Stewart J., Siziopikou, Kalliopi P., Arthur, Douglas W, Julian, Thomas B., Rabinovitch, Rachel, Parda, David S., Seaward, Samantha A., Carter, Dennis L., Lyons, Janice A., Dillmon, Melissa S., Magrinat, Gustav, Kavadi, Vivek S, Zibelli, Allison M., Tiriveedhi, Lavanya, Hill, Matthew L., Melnik, Marianne, Beriwal, Sushil, Mamounas, Eleftherios P., Wolmark, Norman

“…Abstract only 508 Background: Preclinical studies report that T can boost RT effectiveness. The primary aim of this trial assessed the efficacy of concurrent T…”
Get full text

A collaborative pilot model among Georgia oncologists to strengthen clinical trial enrollment and promote equity of care for minorities by Ghamande, Sharad A., Cantuaria, Guilherme, Jillella, Anand P., Kota, Vamsi, Green, Andrew Emmons, Richards, William, Burke, James J, Zaren, Howard A., Taylor, Mark A., Reddy, Sreekanth, Dillmon, Melissa S., Pippas, Andrew William, Schnell, Frederick M., Srinivasiah, Jayanthi, McDonough, Colleen H., Short, Joni, Whitaker, Geri, Belgrave, Aprille, Paris, Nancy M.

“…Abstract only…”
Get full text